PATECIBART
UNII K3KZN98GF5

Substance Identification & Data

This profile provides standardized clinical and technical data for Patecibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) K3KZN98GF5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2642374-04-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
K3KZN98GF5
CAS Registry Number
2642374-04-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
PATECIBART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C199087
National Cancer Institute reference terminology for clinical and research data.
INN ID
12333
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Patecibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PATECIBART

Common Names & Synonyms

GETAGOZUMAB
GMA-301
IMMUNOGLOBULIN G4 (228-PROLINE,234-ALANINE,235-ALANINE,DE-447-LYSINE), ANTI-(HUMAN ENDOTHELIN ETA RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL GMA301 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL GMA301 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS EDNRA (ENDOTHELIN RECEPTOR TYPE A, ETA, ET-A, ETA-R, ET-AR)), HUMANIZED MONOCLONAL ANTIBODY (GAMMA4 HEAVY CHAIN HUMANIZED (1-446) (VH (HOMO SAPIENS IGHV2-5*09 (88.9%) -(IGHD) -IGHJ4*01 (93.3%), CDR-IMGT (10.7.12) (26-35.53-59.98-109)) (1-120)-HOMO SAPIENS IGHG4*01, NG4M(A) CH2 L92,G4V5 H P10, G4V4 CH2 A1.3, A1.2 (CH1 (121-218), HINGE 1-12 S10>P (228) (219-230), CH2 F1.3>A (234), L1.2>A (235), L92 (309) (231-340), CH3 (341-445), CHS K2>DEL (446)) (121-446)), (134-214')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-214') (V-KAPPA (HOMO SAPIENS IGKV6-21*02 (90.5%)-IGKJ1*01 (100%), CDR-IMGT (6.3.9) (27-32.50-52.89-97)) (1'-107') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (153), V101 (191) (108'-214')); DIMER (226-226'':229-229'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELL LINE, GLYCOFORM ALFA)
PATECIBART [INN]

Technical Codes

GMA301

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus